Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Vivani Medical Inc
VANI
Healthcare
Medical Devices
Vivani Medical, Inc. is a biopharmaceutical company developing novel, ultra-long-acting drug implants. Leveraging its NanoPortal platform, the Company develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and potentially to improve patient tolerance to their medication. Its lead program, NPM-115...
, utilizes a miniature, six-month, subdermal, GLP-1 (exenatide) implant under development for the treatment of chronic weight management in obese or overweight individuals. Its pipeline also includes the NPM-139 (semaglutide) implant which is also under development for chronic weight management in obese and overweight individuals. NPM-119 refers to its Type II diabetes development program. OKV-119 is an exenatide implant that is under development for metabolic diseases in cats, including for the treatment of obesity and diabetes. Its segments include Biopharm Division and Neurostimulation Division.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:VANI)
New Post
View:
Posts & Comments
Threaded Posts
(9)
•••
MikeTester
X
View Profile
View Bullboard History
Post by
MikeTester
on Aug 03, 2024 3:30pm
Vivani Medical, Inc. (NASDAQ:VANI): Innovative Miniature Imp
https://beyondspx.com/2024/08/03/vivani-medical-inc-nasdaqvani-innovative-miniature-implants-poised-to-transform-chronic-disease-management/
(0)
•••
LocomotiveB
X
View Profile
View Bullboard History
Post by
LocomotiveB
on Jun 08, 2021 11:05am
Chat with Dr. Robert Greenberg, former CEO of Second Sight
Dr. Robert Greenberg, current Chairman and CEO of Alfred Mann Foundation and former CEO of Second Sight Medical Products, shares his experience at the helm of one of the world’s most
...more
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on May 12, 2021 2:02pm
EYES...big runner this a.m
Now in PB mode ......has to hold $6.12 or she be head south to 2nd target of $5.74 Cheers !
(42)
•••
Kruithof
X
View Profile
View Bullboard History
Comment by
Kruithof
on Mar 15, 2021 1:03am
RE:ACDC
https://m.youtube.com/watch?v=SsA2yXyh7gs&t=306s
(42)
•••
Kruithof
X
View Profile
View Bullboard History
Post by
Kruithof
on Mar 13, 2021 5:30pm
ACDC
https://ca.finance.yahoo.com/news/minto-apartment-reit-reports-third-220000314.html
(42)
•••
Kruithof
X
View Profile
View Bullboard History
Comment by
Kruithof
on Mar 10, 2021 3:19am
RE:RE:ACDC
https://www.streetwisereports.com/article/2021/03/09/the-future-of-battery-storage-and-management.html?fbclid=IwAR1uoXKBPeBr2quoGNfp8movmH5chlv7LimFaylkQA6MZZGmgMliVRP-Sik
(42)
•••
Kruithof
X
View Profile
View Bullboard History
Comment by
Kruithof
on Mar 09, 2021 7:40pm
RE:ACDC
https://evbattery.tech/investors/
(42)
•••
Kruithof
X
View Profile
View Bullboard History
Post by
Kruithof
on Mar 09, 2021 11:09am
ACDC
https://ionixpro.com/product/ionix-pro-home-smart-wall-pre-order/
(34)
•••
Spartan17
X
View Profile
View Bullboard History
Comment by
Spartan17
on Mar 09, 2021 9:20am
RE:+304% today.
crazy its at $20 today.
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Why Dozens of Pro Athletes are Paying Attention to this Product
Do you want to stay ahead of the markets? See how DealRoom can help.
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Learn How this Company is Disrupting Point-of-Care Testing